Buprenorphine Maintenance for Opiate Dependence - 6
Phase 2
Completed
- Conditions
- Opioid-Related DisordersSubstance-Related Disorders
- Registration Number
- NCT00000357
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Brief Summary
The purpose of this study is to determine the efficacy of buprenorphine as a substitution pharmacotherapy for opiate dependence.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie buprenorphine's efficacy in treating opioid dependence as studied in NCT00000357?
How does buprenorphine compare to methadone in long-term opiate maintenance therapy outcomes?
Are there specific biomarkers that predict response to buprenorphine in opioid use disorder patients?
What adverse events were observed in NCT00000357 and how were they managed during treatment?
What combination therapies with buprenorphine have shown improved outcomes for opioid dependence?
Trial Locations
- Locations (1)
University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States
University of Pennsylvania🇺🇸Philadelphia, Pennsylvania, United States